These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2144208)

  • 1. Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86.
    Iversen P; Suciu S; Sylvester R; Christensen I; Denis L
    Cancer; 1990 Sep; 66(5 Suppl):1067-73. PubMed ID: 2144208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoladex plus flutamide vs. orchidectomy for advanced prostatic cancer. Danish Prostatic Cancer Group (DAPROCA).
    Iversen P
    Eur Urol; 1990; 18 Suppl 3():41-4. PubMed ID: 2151275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study. The EORTC GU Group.
    Keuppens F; Denis L; Smith P; Carvalho AP; Newling D; Bond A; Sylvester R; De Pauw M; Vermeylen K; Ongena P
    Cancer; 1990 Sep; 66(5 Suppl):1045-57. PubMed ID: 2144206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparability of EORTC and DAPROCA studies in advanced prostatic cancer.
    Suciu S; Sylvester R; Iversen P; Christensen I; Denis L
    Cancer; 1990 Sep; 66(5 Suppl):1029-34. PubMed ID: 2144205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate.
    Iversen P; Christensen MG; Friis E; Hornbøl P; Hvidt V; Iversen HG; Klarskov P; Krarup T; Lund F; Mogensen P
    Cancer; 1990 Sep; 66(5 Suppl):1058-66. PubMed ID: 2144207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group.
    Denis L; Smith PH; De Moura JL; Newling DW; Bono A; Keuppens F; Robinson M; Mahler C; Sylvester R; De Pauw M
    Eur Urol; 1990; 18 Suppl 3():34-40. PubMed ID: 2151274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orchidectomy versus Zoladex plus Eulexin in patients with metastatic prostate cancer (EORTC 30853).
    Denis L; Robinson M; Mahler C; Smith P; Keuppens F; De Moura JL; Bono A; Newling D; Sylvester R; De Pauw M
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):951-9. PubMed ID: 2149508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group.
    Smith PH; Bono A; Calais da Silva F; Debruyne F; Denis L; Robinson P; Sylvester R; Armitage TG
    Cancer; 1990 Sep; 66(5 Suppl):1009-16. PubMed ID: 2144203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EORTC protocol 30853: orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Interim statistical analysis of the side effects of treatment.
    Robinson MR; Denis L; Newling DW; Sylvester R; De Pauw M
    Cancer; 1990 Sep; 66(5 Suppl):1022-4. PubMed ID: 2144204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled study.
    Fourcade RO; Cariou G; Coloby P; Colombel P; Coulange C; Grise P; Mangin P; Soret JY; Poterre M
    Eur Urol; 1990; 18 Suppl 3():45-7. PubMed ID: 2151276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.
    Peeling WB
    Urology; 1989 May; 33(5 Suppl):45-52. PubMed ID: 2523611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
    Sylvester RJ; Denis L; de Voogt H
    Eur Urol; 1998; 33(2):134-43. PubMed ID: 9519354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of Danish Prostatic Cancer Group trial 86. Goserelin acetate plus flutamide versus orchiectomy in advanced prostate cancer.
    Iversen P; Rasmussen F; Klarskov P; Christensen IJ
    Cancer; 1993 Dec; 72(12 Suppl):3851-4. PubMed ID: 8252502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP).
    Boccardo F; Decensi A; Guarneri D; Rubagotti A; Oneto F; Martorana G; Giuliani L; Delli Ponti U; Petracco S; Cortellini P
    Eur Urol; 1990; 18 Suppl 3():48-53. PubMed ID: 2151277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancer.
    Cooper EH; Armitage TG; Robinson MR; Newling DW; Richards BR; Smith PH; Denis L; Sylvester R
    Cancer; 1990 Sep; 66(5 Suppl):1025-8. PubMed ID: 1697498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete androgen blockade: data from an EORTC 30853 trial.
    Denis L; Keuppens F; Robinson M; Mahler C; Smith P; Pinto de Carvalho AP; Newling D; Bono A; Sylvester R; De Pauw M
    Semin Urol; 1990 Aug; 8(3):166-74. PubMed ID: 2144656
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer.
    Schulze H; Kaldenhoff H; Senge T
    Urol Int; 1988; 43(4):193-7. PubMed ID: 2973169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853). European Organization for Research and Treatment of Cancer--Genitourinary Group.
    Keuppens F; Whelan P; Carneiro de Moura JL; Newling D; Bono A; Denis L; Robinson M; Mahler C; Sylvester R; De Pauw M
    Cancer; 1993 Dec; 72(12 Suppl):3863-9. PubMed ID: 8252505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total androgen ablation: European experience. The EORTC GU Group.
    Denis L; Smith P; Carneiro de Moura JL; Newling D; Bono A; Keuppens F; Mahler C; Robinson M; Sylvester R; De Pauw M
    Urol Clin North Am; 1991 Feb; 18(1):65-73. PubMed ID: 1825144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center.
    Denis LJ; Keuppens F; Smith PH; Whelan P; de Moura JL; Newling D; Bono A; Sylvester R
    Eur Urol; 1998; 33(2):144-51. PubMed ID: 9519355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.